Novel Targeted Therapy for Low-Grade Lymphoid Malignancies in Older Adults by Dr. Krem
Dr. Krem discusses age-related and biological factors for low-grade lymphoma pathogenesis and outcomes. He then explains the mechanisms of action from low-grade lymphoma therapies. He finishes by applying recent efficacy and toxicity data to older patients with low-grade lymphoma.
Maxwell M. Krem, M.D., P.h.D.
Dr. Maxwell Krem is a medical oncologist who sees patients with hematologic malignancies at James Graham Brown Cancer Center (JGBCC), University of Louisville School of Medicine. His primary specialty is bone marrow transplantation. Dr. Krem recalls an experience he had as a young person when his grandfather had cancer. “I saw a lack of bedside manner and a lack of sensitivity,” he says, adding “It really made a big impression on me... I knew I could do better so I’ve tried to develop a humanistic approach in my rapport with patients and their families. I try to be a source of support, whatever the outcome."